Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Theravance Biopharma, Inc. (TBPH) had Current Ratio of 13.54 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$20.73M |
|
$-5.90M |
|
-- |
|
$20.73M |
|
$29.01M |
|
$-8.28M |
|
$3.49M |
|
$-4.79M |
|
$-4.79M |
|
$-5.90M |
|
$-5.90M |
|
$-5.90M |
|
$-5.90M |
|
$-8.28M |
|
$-8.85M |
|
51.67M |
|
51.67M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$416.66M |
|
$5.17M |
|
$53.11M |
|
$469.77M |
|
$30.77M |
|
-- |
|
$149.30M |
|
$180.06M |
|
$289.70M |
|
$289.70M |
|
$289.70M |
|
51.89M |
|
| Cash Flow Statement Financials | |
$66.31M |
|
$-7.81M |
|
$-6.54M |
|
$168.64M |
|
$220.60M |
|
$51.96M |
|
$10.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
13.54 |
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-39.93% |
|
-39.93% |
|
-- |
|
-23.11% |
|
-28.45% |
|
$66.31M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
1.02 |
|
88.48 |
|
-2.04% |
|
-2.04% |
|
-1.26% |
|
-2.04% |
|
$5.58 |
|
$1.28 |
|
$1.28 |
|